Vasopressin Global Market Report 2025

Description

Vasopressin, also referred to as antidiuretic hormone (ADH), is a peptide hormone produced by the hypothalamus and secreted by the posterior pituitary gland into the bloodstream. It plays a pivotal role in regulating the body's water balance, blood pressure, and response to stress.

The primary product types of vasopressin include intravenous injection, intramuscular injection, and subcutaneous injection. Intravenous injection involves delivering the hormone directly into the bloodstream. These formulations find application in various medical conditions such as anti-diuretic hormone deficiency, vasodilatory shock, gastrointestinal bleeding, ventricular tachycardia and fibrillation, and are utilized by a range of end-users including hospitals, clinics, and other medical facilities.

The vasopressin market research report is one of a series of new reports from The Business Research Company that provides vasopressin market statistics, including vasopressin industry global market size, regional shares, competitors with a vasopressin market share, detailed vasopressin market segments, market trends, and opportunities, and any further data you may need to thrive in the vasopressin industry. This vasopressin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vasopressin market size has grown rapidly in recent years. It will grow from $1.38 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to increased senior population, hospital and healthcare infrastructure development, increased prevalence of autonomic dysreflexia, increased consciousness among medical professionals, and high prevalence of chronic diseases.

The vasopressin market size is expected to see rapid growth in the next few years. It will grow to $2.71 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to growing prevalence of diabetes insipidus, improvements in medication delivery systems, enhanced knowledge and diagnosis, research and development initiatives, and increasing awareness about diabetes. Major trends in the forecast period include technological developments in manufacturing, innovations in formulations and delivery techniques, personalized approach for multimodal treatment is new therapeutic approach, focus on health and wellness, and personalization and customization.

The increasing prevalence of diabetes is expected to drive the growth of the vasopressin market in the coming years. Diabetes is a chronic condition characterized by high blood sugar levels, caused by the body's inability to produce or effectively use insulin. The rise in diabetes cases is linked to factors such as increasing obesity rates, mental health issues, stress, and genetic predisposition. Vasopressin plays a critical role in managing central diabetes insipidus by helping to restore normal water balance and alleviating symptoms like excessive thirst and urination. For example, in June 2024, the National Health Service (NHS), a UK-based government department, reported that the number of diabetes cases among individuals under 40 grew from 173,166 in 2022 to 216,440 in 2023, indicating a significant rise in the prevalence of diabetes in younger populations. As a result, the growing number of diabetes cases is driving the demand for vasopressin.

Innovative products such as pre-mix ready-to-use (RTU) injection bottles are being developed by major companies in the vasopressin market to enhance convenience and patient safety. These RTU bottles mitigate preparation errors and contamination risks while ensuring precise dosing. For example, Endo International plc introduced VASOSTRICT (vasopressin injection, USP) in ready-to-use 100 mL pre-mix bottles in February 2022. This formulation, the first of its kind, offers improved inventory management and a two-year shelf life, with up to 12 months at room temperature. It is supplied as a clear solution for intravenous administration in single-dose vials containing 20 units per mL or multiple-dose vials containing 200 units per 10 mL.

In May 2022, Fresenius Kabi acquired Ivenix Inc. for $240 million to strengthen its position in the U.S. market with an advanced infusion therapy platform. Ivenix Inc., a medical technology company specializing in infusion therapy solutions, offers vasopressin injection, further expanding Fresenius Kabi's portfolio and hospital connectivity.

Major companies operating in the vasopressin market are Pfizer Inc., Merck KGaA, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Limited, Dr. Reddys Laboratories Ltd., Apotex Inc., Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals Inc., Ferring Pharmaceuticals, Amphastar Pharmaceuticals Inc., Bachem Holding AG, Eagle Pharmaceuticals Inc., Par Pharmaceutical Holdings Inc., Athenex Inc., Soho-Yiming Pharmaceuticals Co. Ltd., Nordic Pharma Inc., Cumberland Pharmaceuticals Inc., Laboratorio ELEA S.A.C.I.F. y A., Fresenius Kabi Canada Ltd., AMOMED Pharma GmbH, BCN Peptides SA, Hainan Zhonghe Pharmaceutical Co. Ltd., Denovo Biopharma LLC

North America was the largest region in the vasopressin market in 2024. The regions covered in the vasopressin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vasopressin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vasopressin market consists of sales of arginine vasopressin (AVP), vasopressin receptor, oral tablets, sublingual tablets, nasal sprays, and oil-repository material. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vasopressin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vasopressin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vasopressin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vasopressin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Intravenous Injection; Intramuscular Injection; Subcutaneous Injection
2) By Application: Anti-Diuretic Hormone Deficiency; Vasodilatory Shock; Gastrointestinal Bleeding; Ventricular Tachycardia And Fibrillation
3) By End-User: Hospitals; Clinics; Other End Users
Subsegments:
1) By Intravenous Injection: Standard Iv Vasopressin Injection; High-Dose Iv Vasopressin Injection; Iv Vasopressin For Sepsis And Shock Treatment; Iv Vasopressin For Post-Operative Care
2) By Intramuscular Injection: Standard Im Vasopressin Injection; Intramuscular Vasopressin For Hormonal Imbalance; Vasopressin Injection For Acute Hemorrhage Control
3) By Subcutaneous Injection: Subcutaneous Vasopressin For Diabetes Insipidus; Vasopressin Injection For Fluid Retention Treatment; Long-Acting Subcutaneous Vasopressin Formulations
Companies Mentioned: Pfizer Inc.; Merck KGaA; Baxter International Inc.; Otsuka Pharmaceutical Co. Ltd.; Aurobindo Pharma Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r31469

1. Executive Summary

2. Vasopressin Market Characteristics

3. Vasopressin Market Trends And Strategies

4. Vasopressin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Vasopressin Growth Analysis And Strategic Analysis Framework

5.1. Global Vasopressin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Vasopressin Market Growth Rate Analysis
5.4. Global Vasopressin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Vasopressin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Vasopressin Total Addressable Market (TAM)

6. Vasopressin Market Segmentation

6.1. Global Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Injection
Intramuscular Injection
Subcutaneous Injection
6.2. Global Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anti-Diuretic Hormone Deficiency
Vasodilatory Shock
Gastrointestinal Bleeding
Ventricular Tachycardia And Fibrillation
6.3. Global Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Other End Users
6.4. Global Vasopressin Market, Sub-Segmentation Of Intravenous Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Iv Vasopressin Injection
High-Dose Iv Vasopressin Injection
Iv Vasopressin For Sepsis And Shock Treatment
Iv Vasopressin For Post-Operative Care
6.5. Global Vasopressin Market, Sub-Segmentation Of Intramuscular Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Im Vasopressin Injection
Intramuscular Vasopressin For Hormonal Imbalance
Vasopressin Injection For Acute Hemorrhage Control
6.6. Global Vasopressin Market, Sub-Segmentation Of Subcutaneous Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subcutaneous Vasopressin For Diabetes Insipidus
Vasopressin Injection For Fluid Retention Treatment
Long-Acting Subcutaneous Vasopressin Formulations

7. Vasopressin Market Regional And Country Analysis

7.1. Global Vasopressin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Vasopressin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vasopressin Market

8.1. Asia-Pacific Vasopressin Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vasopressin Market

9.1. China Vasopressin Market Overview
9.2. China Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vasopressin Market

10.1. India Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vasopressin Market

11.1. Japan Vasopressin Market Overview
11.2. Japan Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vasopressin Market

12.1. Australia Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vasopressin Market

13.1. Indonesia Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vasopressin Market

14.1. South Korea Vasopressin Market Overview
14.2. South Korea Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vasopressin Market

15.1. Western Europe Vasopressin Market Overview
15.2. Western Europe Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vasopressin Market

16.1. UK Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vasopressin Market

17.1. Germany Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vasopressin Market

18.1. France Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vasopressin Market

19.1. Italy Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vasopressin Market

20.1. Spain Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vasopressin Market

21.1. Eastern Europe Vasopressin Market Overview
21.2. Eastern Europe Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vasopressin Market

22.1. Russia Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vasopressin Market

23.1. North America Vasopressin Market Overview
23.2. North America Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vasopressin Market

24.1. USA Vasopressin Market Overview
24.2. USA Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vasopressin Market

25.1. Canada Vasopressin Market Overview
25.2. Canada Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vasopressin Market

26.1. South America Vasopressin Market Overview
26.2. South America Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vasopressin Market

27.1. Brazil Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vasopressin Market

28.1. Middle East Vasopressin Market Overview
28.2. Middle East Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vasopressin Market

29.1. Africa Vasopressin Market Overview
29.2. Africa Vasopressin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Vasopressin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Vasopressin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vasopressin Market Competitive Landscape And Company Profiles

30.1. Vasopressin Market Competitive Landscape
30.2. Vasopressin Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

31. Vasopressin Market Other Major And Innovative Companies

31.1. Dr. Reddys Laboratories Ltd.
31.2. Apotex Inc.
31.3. Amneal Pharmaceuticals Inc.
31.4. Endo Pharmaceuticals Inc.
31.5. Mallinckrodt Pharmaceuticals Inc.
31.6. Ferring Pharmaceuticals
31.7. Amphastar Pharmaceuticals Inc.
31.8. Bachem Holding AG
31.9. Eagle Pharmaceuticals Inc.
31.10. Par Pharmaceutical Holdings Inc.
31.11. Athenex Inc.
31.12. Soho-Yiming Pharmaceuticals Co. Ltd.
31.13. Nordic Pharma Inc.
31.14. Cumberland Pharmaceuticals Inc.
31.15. Laboratorio ELEA S.A.C.I.F. y A.

32. Global Vasopressin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vasopressin Market

34. Recent Developments In The Vasopressin Market

35. Vasopressin Market High Potential Countries, Segments and Strategies

35.1 Vasopressin Market In 2029 - Countries Offering Most New Opportunities
35.2 Vasopressin Market In 2029 - Segments Offering Most New Opportunities
35.3 Vasopressin Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer